News

Amgen has issued the statement on the outcome of meeting with the FDA’s Advisory Committee for Reproductive Health Drugs (ACRHD), to review the potential use of Prolia (denosumab).

Herbalife has sealed an agreement to buy certain assets of Micelle Laboratories (Micelle), in order to strengthen its global manufacturing capabilities. The Micelle facility is FDA-certified and is

Continucare Corporation (Continucare) has expanded its service offerings through the acquisition of Professional Sleep Diagnostics. Continucare said that the company’s sleep service activities will be conducted through its

Cyanotech has reported increase in revenues by 9% to $4m, for the first quarter of 2010, compared to revenues of $3.7m for the first quarter of 2009. Gross

BioSante has provided positive safety data in its ongoing LibiGel phase III clinical development program. The phase III Cardiovascular and Breast Cancer Safety Study is a randomized, double-blind,

Sales of patch products rose moderately to $9.9 million in the second quarter of 2009, accounting for 30.9% of revenue, compared to 37% a year ago. Sales of

OncoGenex has reported the first patient dosing in an open label, dose-escalation, phase 1 clinical trial, evaluating OGX-427 when administered directly into the bladder in patients with bladder

Bio-Matrix Scientific Group (BMSN) has entered into a Letter of Intent (LOI) with Therinject contemplating the development of a new immuno-therapeutic cancer vaccine. The LOI, which is subject

Acacia Research has announced that its subsidiary, Acacia Patent Acquisition, has acquired rights to a patent for biosensor technology. The patented technology generally relates to biosensors, such as